Virax Biolabs Group Limited (VRAX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Virax Biolabs Group Limited  (NASDAQ: VRAX)

Virax Biolabs Group Limited Profitability Comparisons

Select each Category to receive further Information




VRAX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) - 57.22 % 66.51 % 45.05 %
Gross Margin (Q1 TTM) - 56.8 % 64.81 % 44.77 %
Gross Profit Margin 5 Yr. Avg. - 59.88 % 65.28 % 46.95 %
EBITDA Margin (Q1 MRQ) - -47.45 % 12.52 % 21.56 %
EBITDA Margin (Q1 TTM) - 3.44 % 14.36 % 19.3 %
EBITDA Margin 5 Yr. Avg. - 14.29 % 26.02 % 21.13 %
Operating Margin (Q1 MRQ) - -57.96 % 8.9 % 15 %
Operating Margin (Q1 TTM) - -5.93 % 9.16 % 14.52 %
Operating Margin 5 Yr. Avg. - 7.81 % 13.31 % 16 %
Pre-Tax Profit Margin (Q1 MRQ) - -57.47 % 3.53 % 11.22 %
Pre-Tax Profit Margin (Q1 TTM) - -7.32 % 4.73 % 10.49 %
Pre-Tax Profit Margin 5 Yr. Avg. - 6.6 % 9.87 % 11.31 %
Net Margin (Q1 MRQ) - -57.24 % 1.84 % 8.85 %
Net Margin (Q1 TTM) - -9.52 % 5.48 % 8.65 %
Net Margin 5 Yr. Avg. - 2.64 % 7.17 % 9.1 %



Business Segment Profit Margin